
Why Innovation and Access Matter to Dr. John M. Rosen, Pediatric Neurogastroenterologist
In this episode of Matters.com Presents, Mike interviews John M. Rosen. John M. Rosen, a pediatric neurogastroenterologist and digital health innovator, sits down to talk about what really matters to him right now: using technology to improve healthcare access for kids. From telehealth visits that help a teenager with autism get care from the comfort of his own couch, to AI-powered tools that put health information directly in the hands of parents, John makes a compelling case for why innovation in pediatric GI care is long overdue. He also pulls back the curtain on Pooficient , his new app designed to help families tackle constipation and GI health — and yes, even shares the story of taking his own toddler to the ER for what turned out to be constipation after all his years of training. [00:22] John M. Rosen shares what matters most to him: using technology to improve kids' health [00:33] How telehealth is eliminating the need for families to travel hundreds of miles to see specialists [00:54] A real-world example: how virtual visits transformed care for a teenager with autism [02:38] How digital record-sharing and AI are putting health knowledge in parents' hands [03:18] Introducing Pooficient: the app helping families navigate pediatric GI health [04:51] The surprising scale of childhood constipation and why it's still a taboo topic [06:20] John M. Rosen's honest confession: taking his own toddler to the ER for constipation [07:49] The sophisticated AI behind Pooficient and what makes it stand out [08:07] Speed round begins [08:22] Matters.com Speed Round: Pediatric Gastroenterology, Pizza, Telemedicine, Artificial Intelligence, Coffee, Mental Health You can find John M. Rosen at: https://www.linkedin.com/in/johnmrosen/ https://www.pooficient.com/ This podcast is brought to you by Matters.com. A new social media and collaboration platform - launching soon. Join thousands getting the Matters.com newsletter — world news, fresh perspectives, and early beta access.














